These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20006707)

  • 21. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
    Lee SH; Chung BH; Park TG; Nam YS; Mok H
    Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design.
    Buyens K; De Smedt SC; Braeckmans K; Demeester J; Peeters L; van Grunsven LA; de Mollerat du Jeu X; Sawant R; Torchilin V; Farkasova K; Ogris M; Sanders NN
    J Control Release; 2012 Mar; 158(3):362-70. PubMed ID: 22023849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
    Andersen MØ; Howard KA; Kjems J
    Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to successful delivery of short interfering RNA after systemic administration.
    White PJ
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytes.
    Sebestyén MG; Wong SC; Trubetskoy V; Lewis DL; Wooddell CI
    Methods Mol Biol; 2015; 1218():163-86. PubMed ID: 25319651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
    Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
    Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges.
    Bardoliwala D; Patel V; Javia A; Ghosh S; Patel A; Misra A
    Ther Deliv; 2019 May; 10(5):311-332. PubMed ID: 31116099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix systems for siRNA delivery.
    Naeye B; Raemdonck K; Remaut K; Demeester J; De Smedt SC
    Curr Top Med Chem; 2012; 12(2):89-96. PubMed ID: 22196275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
    Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
    Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
    Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chitosan-siRNA complex nanoparticles for gene silencing].
    Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo.
    Choi KM; Kim K; Kwon IC; Kim IS; Ahn HJ
    Mol Pharm; 2013 Jan; 10(1):18-25. PubMed ID: 22663765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.
    Ramsey JM; Hibbitts A; Barlow J; Kelly C; Sivadas N; Cryan SA
    Ther Deliv; 2013 Jan; 4(1):59-76. PubMed ID: 23323781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery.
    Abeylath SC; Ganta S; Iyer AK; Amiji M
    Acc Chem Res; 2011 Oct; 44(10):1009-17. PubMed ID: 21761902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in targeted delivery of small interfering RNA using simple bioconjugates.
    Nielsen C; Kjems J; Sørensen KR; Engelholm LH; Behrendt N
    Expert Opin Drug Deliv; 2014 May; 11(5):791-822. PubMed ID: 24669756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipase A2 sensitive liposomes for delivery of small interfering RNA (siRNA).
    Foged C; Nielsen HM; Frokjaer S
    J Liposome Res; 2007; 17(3-4):191-6. PubMed ID: 18027239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced cellular uptake and gene silencing activity of siRNA molecules mediated by chitosan-derivative nanocomplexes.
    Guzman-Villanueva D; El-Sherbiny IM; Vlassov AV; Herrera-Ruiz D; Smyth HD
    Int J Pharm; 2014 Oct; 473(1-2):579-90. PubMed ID: 25063077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.